Stocks
BridgeBio (BBIO) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -765.7% | -511.9% | -6 078% | -196.9% | -134.0% | -103.6% | ||
| Changes by years, y/y, % | +4 880pp | +254pp | -5 566pp | +5 881pp | +63pp | -52.7% | |||
BridgeBio. EBITDA margin, %
BridgeBio. EBITDA margin, changes, pp
BridgeBio (BBIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -108.2% | -129.1% | -143.6% | -116.9% | -53.9% | -103.6% | |
| Changes by years, y/y, % | -103pp | +2 225pp | +4 968pp | +3 879pp | +54pp | |||
| Changes by quarters, q/q, % | +3 888pp | -21pp | -15pp | +27pp | +63pp | |||
